Global Biopharma Solutions Leader Selects Kneat to Drive Digital Validation Excellence

Core Insights - Kneat.com, inc. has entered into a Master Services Agreement with a leading biopharma research and manufacturing technologies provider, marking a significant partnership for the company [1][3] - The biopharma company, which has over 13,000 employees and operates in more than 60 locations globally, will implement Kneat's platform for equipment validation across its manufacturing sites [2][4] - This partnership is expected to enhance operational excellence and long-term value by standardizing validation processes [4] Company Overview - Kneat Solutions specializes in digital validation and compliance for highly regulated industries, offering the Kneat Gx platform [5] - The platform is recognized for its efficiency, reducing validation documentation man-hours by up to 50% and accelerating review and approval cycles by up to 50% [5] - Kneat Gx is fully certified under ISO 9001 and ISO 27001, and compliant with 21 CFR Part 11/Annex 11, ensuring high standards of regulatory compliance [5] Strategic Importance - The partnership with the biopharma company is seen as a strategic win that reinforces Kneat's position as an industry standard for digital validation [3] - The collaboration is anticipated to lead to continued strong revenue growth as the biopharma company expands its use of Kneat's platform across its organization [3]